What it sells
We bank your stem cells to help you live healthier, longer.
Business model breakdown
Buyer: who owns the budget?
Individual consumers paying out of pocket (HSA/FSA eligible), typically health- and longevity-minded adults.
Trigger: what makes them buy now?
Wanting to preserve younger cells now for potential future therapies; the site pitches banking early because cell quality declines with age ("Why bank my cells now?").
Workflow: what inputs become what output?
Choose a collection (blood, skin fibroblasts, or stem cells), have an at-home blood draw or a physician-performed biopsy/collection, cells are cryopreserved in an ISO-accredited biobank, and the customer can later request retrieval through a physician; the Complete Baseline DNA/methylation reading is included with Lifetime plans.
Economics: what it saves and how it charges
UnverifiedDirect-to-consumer storage fees: one-time collection/processing plus annual or lifetime storage plans, with the Complete Baseline DNA sequencing as an add-on or bundled in Lifetime plans.
Distribution: how it reaches customers
Direct online enrollment (onboard flow with annual and lifetime plans), a board-certified physician/clinic network for collections, and content marketing (articles, podcast).
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| — | Y Combinator Summer 2017 | — | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.